Regulatory News In Brief
This article was originally published in The Tan Sheet
Executive Summary
NAD finds Nitraflex “strength” claim weak; FDA nixes BPA coating in infant formula packaging; Herbs of Light in the dark on GMPs, claims; AHPA floats softer Prop 65 warnings; and U.K. aims to end unlicensed herbal sales.
You may also be interested in...
Clean Bill Of Health For BPA In Europe As FDA Examination Continues
EFSA’s conclusion differs from decisions in Canada and the U.S. banning use of the substance as an epoxy resin coating in infant formula packaging. But EFSA lowers its “tolerable daily intake” level for BPA from 50 micrograms to 4 micrograms per kilogram of body weight.
Clean Bill Of Health For BPA In Europe As FDA Examination Continues
EFSA’s conclusion differs from decisions in Canada and the U.S. decision banning use of the substance as an epoxy resin coating in infant formula packaging. But EFSA lowers its “tolerable daily intake” level for BPA from 50 micrograms to 4 micrograms per kilogram of body weight.
Clean Bill Of Health For BPA In Europe As FDA Examination Continues
EFSA’s conclusion differs from decisions in Canada and the U.S. decision banning use of the substance as an epoxy resin coating in infant formula packaging. But EFSA lowers its “tolerable daily intake” level for BPA from 50 micrograms to 4 micrograms per kilogram of body weight.